Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026Dr. Rongliang Lou, PhDExecutive Director, Innovative Drug Research Department at InnoventbioSpeaker
Profile
Dr. Rongliang Lou is a medicinal chemist with a Ph.D. from the Chinese Academy of Sciences. He co-invented Samidorphan, a key component of the FDA-approved drug Lybalvi (2021), and pioneered the novel antibiotic Radezolid into clinical development. Currently, he serves as an Executive Director at Innovent, focusing on development of innovative ADC technologies.
Agenda Sessions
Bispecific and Dual-Payload Strategies for Developing Next-Generation ADCs
, 09:30View Session